feed,title,long_url,short_url
Benzinga,"Sarepta Therapeutics' FDA Adcomm Puts Some Risk, With Potential Approval: Analyst",https://benzinga.com/analyst-ratings/analyst-color/23/03/31402104/sarepta-therapeutics-fda-adcomm-puts-some-risk-with-potential-approval-analyst,https://da.gd/AXFute
